1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Medical Cyclotron Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Medical Cyclotron Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Regulatory Scenario
5.2. Overview of types of cyclotrons currently on the market for various applications
5.3. Technological Advancements
5.4. Cyclotron and Radiopharmaceutical Facilities per region
5.5. COVID-19 Impact Analysis
6. Global Medical Cyclotron Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Cyclotron 10-12 MeV
6.3.2. Cyclotron 16-24 MeV
6.3.3. Cyclotron 24 MeV & above
6.4. Market Attractiveness Analysis, by Product
7. Global Medical Cyclotron Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Diagnosis
7.3.1.1. Oncology
7.3.1.2. Cardiology
7.3.1.3. Neurology
7.3.2. Research
7.4. Market Attractiveness Analysis, by Application
8. Global Medical Cyclotron Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Diagnostics Centers
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Medical Cyclotron Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Medical Cyclotron Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2031
10.2.1. Cyclotron 10-12 MeV
10.2.2. Cyclotron 16-24 MeV
10.2.3. Cyclotron 24 MeV & above
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Diagnosis
10.3.1.1. Oncology
10.3.1.2. Cardiology
10.3.1.3. Neurology
10.3.2. Research
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Diagnostics Centers
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Medical Cyclotron Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Cyclotron 10-12 MeV
11.2.2. Cyclotron 16-24 MeV
11.2.3. Cyclotron 24 MeV & above
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Diagnosis
11.3.1.1. Oncology
11.3.1.2. Cardiology
11.3.1.3. Neurology
11.3.2. Research
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Diagnostics Centers
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. U.K.
11.5.2. Germany
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Medical Cyclotron Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Cyclotron 10-12 MeV
12.2.2. Cyclotron 16-24 MeV
12.2.3. Cyclotron 24 MeV & above
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Diagnosis
12.3.1.1. Oncology
12.3.1.2. Cardiology
12.3.1.3. Neurology
12.3.2. Research
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Diagnostics Centers
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of APAC
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Medical Cyclotron Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Cyclotron 10-12 MeV
13.2.2. Cyclotron 16-24 MeV
13.2.3. Cyclotron 24 MeV & above
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Diagnosis
13.3.1.1. Oncology
13.3.1.2. Cardiology
13.3.1.3. Neurology
13.3.2. Research
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Diagnostics Centers
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Medical Cyclotron Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017–2031
14.2.1. Cyclotron 10-12 MeV
14.2.2. Cyclotron 16-24 MeV
14.2.3. Cyclotron 24 MeV & above
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Diagnosis
14.3.1.1. Oncology
14.3.1.2. Cardiology
14.3.1.3. Neurology
14.3.2. Research
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Diagnostics Centers
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. GE Healthcare
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategies
15.3.1.5. Recent Developments
15.3.2. IBA Radiopharma Solutions
15.3.2.1. Company Overview
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. Business Strategies
15.3.2.5. Recent Developments
15.3.3. Sumitomo Heavy Industries, Ltd.
15.3.3.1. Company Overview
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. Business Strategies
15.3.3.5. Recent Developments
15.3.4. Advanced Cyclotron Systems
15.3.4.1. Company Overview
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. Business Strategies
15.3.4.5. Recent Developments
15.3.5. Siemens Healthineers AG
15.3.5.1. Company Overview
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. Business Strategies
15.3.5.5. Recent Developments
15.3.6. Best Cyclotron Systems, Inc.
15.3.6.1. Company Overview
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. Business Strategies
15.3.6.5. Recent Developments
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer